Core Insights - The "going global" strategy of Chinese AI companies is shifting from a guerrilla approach focused on single products to an ecosystem approach that encompasses the entire industry chain [2][3] - Shenzhen is set to achieve a record high in R&D investment in 2024, exceeding 240 billion yuan, which represents 6.67% of its GDP, the highest proportion in the country [2] - The "Shenzhen-Hong Kong-Guangzhou" innovation cluster has recently ranked first globally in the latest global innovation cluster rankings [2] Industry Trends - AI companies are increasingly forming groups led by "chain master" enterprises to provide comprehensive solutions in overseas markets, particularly in the Middle East [2][3] - There is a strong demand for "intelligent" solutions in the Middle East, but a significant lack of "data" infrastructure, presenting a major opportunity for Shenzhen's full-stack solutions [2][3] Company Strategies - Companies like SenseTime are leading the charge in exporting the entire industry chain, addressing both the "data" and "intelligent" needs of the Middle Eastern market [3] - SenseTime's approach emphasizes that AI technology should solve local problems rather than merely exporting Chinese technology [3][4] - The collaboration between Shenzhen and the Greater Bay Area is viewed as a valuable asset for Chinese tech companies, enhancing their global outreach [4]

商汤医疗是一家专注于人工智能技术在医疗领域应用的公司。该公司早在2018年世界人工智能大会上正 式发布了首款医疗AI产品原型SenseCare智慧诊疗平台。这一平台能够辅助医生进行诊断、制定治疗规 划及康复建议，支持对多种器官的异常检测、识别及自动诊断分析，主要服务于放射科、病理科、放疗 科、外科及骨科等重点临床科室。SenseCare提供全面的诊断服务，产品支持涵盖13个身体部位及器官 的诊断，包括心脏、肝脏、肺、胃、肠及宫颈等。此外，还为医疗专业人员及患者提供三维手术规划及 康复建议。该平台可以部署在本地或云端，采用专有的高并发渲染技术，支持来自不同医疗机构多个终 端的并发访问。 证券之星消息，根据天眼查APP于11月16日公布的信息整理，上海商汤善萃医疗科技有限公司Pre-A+轮 融资，融资额数亿人民币，参与投资的机构包括联想创投，联创资本，九弦资本，上海申冉，凯乘资 本。 | 公布日 | 投资方 | 交易金额 | 融资轮次 | | --- | --- | --- | --- | | 2025-11-16 | 联想创投 联创 各本 九弦资本 | 数亿人民币 | Pre-A+轮 | | | 世世史史 | ...

Core Insights - SenseTime Medical has completed a strategic financing round exceeding 500 million yuan, with investors including Lenovo Capital, Lianchuang Capital, and others [3] - The company is currently initiating its Series A financing, with a post-investment valuation exceeding 3 billion yuan [3] - The company leverages AI technology to promote the construction of "future smart hospitals," utilizing core technologies such as the medical health large language model "Da Yi" and a multimodal medical image foundational model group [3] Financing and Valuation - The recent financing round has surpassed 500 million yuan, contributing to a post-investment valuation of over 3 billion yuan [3] - Previous investments in early 2023 included over 100 million yuan from industry capital such as Midea's Yingfeng Holdings and Renmin Health Publishing Group [3] Technology and Product Development - The "Da Yi" model is based on a large language model with hundreds of billions of parameters, trained on vast amounts of high-quality medical knowledge data, enabling capabilities in self-diagnosis, medication consultation, structured imaging reports, and clinical decision support [3] - The multimodal medical image foundational model group addresses various data modalities, including medical images and biological information, facilitating tasks such as detection, segmentation, and classification [3] Strategic Vision and Market Position - The CEO emphasizes that while pure technology can provide a competitive edge, a rich product matrix and capital-supported industrial ecosystem are harder to replicate [4] - SenseTime Medical has adopted a platform-based strategy since 2018, covering clinical diagnosis, intelligent decision-making, patient services, and medical research [4] - The company aims to avoid price wars in the software market by establishing a dual middle platform system for intelligent model development and application [4] Future Plans and Ecosystem Development - The company plans to continue attracting resourceful shareholders and partners to build an AI medical ecosystem, accelerating the smart upgrade of the healthcare industry [5] - The strategy includes deepening engagement with large hospitals while expanding standardized software modules to grassroots hospitals to increase revenue [4][5]

近日，商汤医疗完成数亿元新一轮战略融资，本轮投资方包括联想创投、联创资本、九弦资本、申冉投资等多家知名投资 机构。同时，商汤医疗已同步启动A轮融资，认购金额超5亿元，投后估值超30亿元。 医疗科技公司都在争夺各种数据入口，一方面积极与各大医院合作，抢占医院端入口，另一方面也在抢占患者端入口，希 望把低频的医疗行为变成高频的健康咨询问诊行为。 如果算上正在进行中的A轮融资，今年以来，商汤医疗已经融到第三轮，且基本由产业侧资本主导，这在资本市场并不火 热的当下引发关注。 AI医疗竞赛进入新阶段 第一财经记者注意到，尽管整体资本市场环境尚未完全回暖，但AI医疗赛道的融资仍较为活跃。就在上周，AI医疗公司全 诊通也宣布了1亿元的B轮融资，由创新医疗以及四川佳能达投资有限公司投资。 就在本月，蚂蚁健康宣布原"数字医疗健康事业部"正式升级为"健康事业群"，并将加速推动医疗健康业务成为蚂蚁的战略 支柱板块。有业内人士将蚂蚁健康此次战略升级视为行业内的标志性事件。 商汤医疗由商汤科技拆分智慧医疗板块而成立，其业务基础主要建立在商汤的SenseCare智慧诊疗平台之上，并依托商汤科 技的底层算法能力，构建了"大医智能体开发平台 ...

11月17日，上海商汤善萃医疗科技有限公司（简称"商汤医疗"）宣布于近日完成数亿元新一轮战略融 资。本轮投资方包括联想创投、联创资本、九弦资本、申冉投资等多家投资机构。 今年年初，商汤医疗已获美的系盈峰控股、人民卫生出版社集团旗下人卫科技发展公司等机构的上亿元 投资。 据介绍，目前商汤医疗已同步启动A轮融资，认购金额超5亿元，投后估值超30亿元。（智通财经记者 秦盛） 商汤医疗成立于2022年。商汤医疗与新加坡IHH医疗(集团)旗下百汇放射科的合作，是2025世界人工智 能大会（WAIC）发布的《中国智·惠世界（2025）》案例集唯一入选的医疗案例。 ...

编辑 杨娟娟 新京报贝壳财经讯 11月17日，据商汤医疗官方公众号消息，近日商汤医疗完成数亿元新一轮战略融 资，本轮投资方包括联想创投、联创资本、九弦资本、申冉投资等多家知名投资机构。目前，商汤医疗 已同步启动A轮融资，认购金额超5亿元，投后估值超30亿元。 ...

Group 1 - The core viewpoint of the news is that SenseTime Medical has completed a new round of strategic financing amounting to hundreds of millions, with investors including Lenovo Ventures, Lianchuang Capital, and others [1] - The funds from this financing round will be used for the continuous iteration of medical large models, expansion and upgrading of core product matrices, and deepening market layout in key regions [1] - Earlier this year, SenseTime Medical received over 100 million in investments from institutions such as Midea Group and Renmin University Health Technology Development Company [1] Group 2 - SenseTime Medical has initiated its Series A financing, with a post-investment valuation exceeding 3 billion, and the subscription amount has already surpassed 500 million [2] - The company, which has been developing for over 7 years, established its research and product capabilities after entering the medical field in 2018, forming a smart health team [2] - SenseTime Medical has developed a medical health large language model called "Daiyi" and a multimodal medical image foundational model group, aiming to promote the construction of "future smart hospitals" [2] Group 3 - The "Daiyi" model is based on SenseTime's "Shangliang" large language model with hundreds of billions of parameters, trained using vast amounts of high-quality medical knowledge data, and is capable of perception, reasoning, and planning [2] - The multimodal medical image foundational model group covers various data modalities including medical images, text, and biological information, and can perform tasks such as detection, segmentation, and classification for different imaging modalities [2] - CEO Zhang Shaoting stated that the company will continue to attract industry partners and financial investors with ecological synergy capabilities to jointly build an AI medical ecosystem and accelerate the intelligent upgrade of the medical industry [2]

Core Insights - SenseTime Medical has completed a new round of strategic financing amounting to several hundred million yuan, with notable investors including Lenovo Capital, Lianchuang Capital, Jiuxian Capital, and Shenran Investment, reflecting strong market recognition of its leading technology, mature business model, and growth potential [1][3] - Earlier this year, SenseTime Medical secured over 100 million yuan in investments from entities such as Midea Group's Yingfeng Holdings and Renmin University Press's subsidiary, enhancing the integration of AI technology in real medical scenarios [1] - The company has initiated Series A financing, with both the scale and market influence of the financing steadily increasing [1] Funding Utilization - The recent financing will be utilized for the continuous iteration of medical large models, expansion and upgrading of core product matrices, and deepening market layout in key regions [3] Upcoming Events - To celebrate the successful completion of this financing round and the commencement of Series A financing, SenseTime Medical will host a ceremony on November 28 titled "Intelligent New Beginnings, Leading the Future - SenseTime Medical's New Journey Launch Ceremony," featuring strategic cooperation signings, future blueprint releases, and a collective appearance by the executive team [3]

Core Viewpoint - SenseTime Medical has completed a new round of strategic financing amounting to several hundred million yuan, with notable investors including Lenovo Capital, Lianchuang Capital, Jiuxian Capital, and Shenran Investment [1] Group 1: Financing and Investment - In early 2023, SenseTime Medical secured over 100 million yuan in investments from Midea Group's Yingfeng Holdings and Renmin University Press Group's subsidiary, Renwei Technology Development [1] - The current round of financing is part of a broader strategy to enhance the integration of AI technology in real medical scenarios, facilitating the transition from technology research and development to industry application [1] - SenseTime Medical has also initiated its Series A financing, with both the scale of financing and market influence steadily increasing [1]

Core Insights - SenseTime Medical has completed a new round of strategic financing amounting to several hundred million yuan, with participation from notable investors including Lenovo Capital, Lianchuang Capital, Jiuxian Capital, and Shenran Investment [1] - The company has also initiated its Series A financing round, with subscription amounts exceeding 500 million yuan and a post-investment valuation exceeding 3 billion yuan [1] Group 1 - The recent financing round attracted multiple well-known investment institutions [1] - The total amount raised in the new financing round is in the hundreds of millions of yuan [1] - The post-investment valuation of SenseTime Medical has surpassed 3 billion yuan [1] Group 2 - The Series A financing round has already begun, indicating ongoing investor interest [1] - Subscription amounts for the Series A round have exceeded 500 million yuan [1]